Ad is loading...
GSPFX
Price
$19.83
Change
-$0.26 (-1.29%)
Updated
Nov 15 closing price
RWMEX
Price
$63.76
Change
-$0.73 (-1.13%)
Updated
Nov 15 closing price
Ad is loading...

GSPFX vs RWMEX

Header iconGSPFX vs RWMEX Comparison
Open Charts GSPFX vs RWMEXBanner chart's image
Gotham Enhanced S&P 500 Index Instl
Price$19.83
Change-$0.26 (-1.29%)
VolumeN/A
CapitalizationN/A
American Funds Washington Mutual R4
Price$63.76
Change-$0.73 (-1.13%)
VolumeN/A
CapitalizationN/A
GSPFX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSPFX vs. RWMEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPFX is a Buy and RWMEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 191B vs. GSPFX (21.4M). RWMEX pays higher dividends than GSPFX: RWMEX (1.45) vs GSPFX (1.27). GSPFX was incepted earlier than RWMEX: GSPFX (8 years) vs RWMEX (23 years). GSPFX is a more actively managed with annual turnover of: 152.00 vs. RWMEX (30.00). RWMEX has a lower initial minimum investment than GSPFX: RWMEX (250) vs GSPFX (5000). GSPFX annual gain was more profitable for investors over the last year : 28.47 vs. RWMEX (18.03). GSPFX return over 5 years is better than : 67.19 vs. RWMEX (37.76).
GSPFXRWMEXGSPFX / RWMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD23.86013.377178%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4M191B0%
Annual Yield % from dividends1.271.4587%
Returns for 1 year28.4718.03158%
Returns for 3 years17.4310.11172%
Returns for 5 years67.1937.76178%
Returns for 10 yearsN/A56.39-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY23.561.17
+5.23%
Lifeway Foods
NOAH11.720.31
+2.72%
Noah Holdings Limited
PEG88.991.99
+2.29%
Public Service Enterprise Group
ANTX1.00N/A
N/A
AN2 Therapeutics
DNB12.12-0.18
-1.46%
Dun & Bradstreet Holdings